Related Experiment Videos
IS THE RISK OF SUDDEN CARDIAC DEATH INCREASED IN CUSHING'S DISEASE AND SYNDROME?
G Koracevic1,2, M Stojanovic1,3, M Stanojkovic1
1University of Nis, Faculty of Medicine, Nis.
Summary
Sudden cardiac death (SCD) is a significant risk in Cushing's syndrome (CS). This review identifies multiple SCD risk factors prevalent in CS, highlighting the need for tailored preventive strategies.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Sudden cardiac death (SCD) accounts for a substantial portion of cardiovascular (CV) mortality.
- Cushing's syndrome (CS) is increasingly recognized as having a very high CV risk.
- The association between CS and SCD risk warrants detailed investigation.
Purpose of the Study:
- To analyze existing literature on the relationship between Cushing's syndrome (CS) and sudden cardiac death (SCD).
- To identify and evaluate cardiovascular risk factors associated with SCD in CS patients.
Main Methods:
- A narrative review approach was employed due to the absence of clinical trials or registries.
- Literature search conducted across multiple databases including SCOPUS, Medline, PubMed, and Oxford Journals.
- Keywords used were "Cushing" and "sudden death".
Main Results:
- A limited number of publications (eight total) were identified, with a significant gap in research over the last three decades.
- Several risk factors (RFs) for SCD were identified as prevalent in patients with CS.
- The scarcity of research indicates that SCD risk in CS has been historically underestimated.
Conclusions:
- The clustering of identified risk factors suggests an elevated risk of SCD in Cushing's syndrome (CS) and Cushing's disease (CD).
- Further research into risk stratification tools for CV events, specifically SCD, is recommended.
- Personalized preventive measures targeting individual CV risk levels in CS patients are crucial for reducing SCD incidence.
Related Concept Videos
Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...